# Limited Competition: National Biocontainment Laboratories (NBLs) Operations Support (UC7 Clinical Trial Not Allowed)

> **NIH NIH UC7** · UNIVERSITY OF TEXAS MED BR GALVESTON · 2024 · $11,500,000

## Abstract

Project Summary/Abstract
The goal of this project is to maintain the Galveston National Laboratory (GNL) at the
University of Texas Medical Branch as a part of the NIAID Biodefense Facilities Network
to provide access to maximum containment research facilities for NIAID funded
investigators, academic collaborators from across the nation and around the world,
commercial partners and others as appropriate. This high containment research
infrastructure and associated facilities is required to safely and securely conduct
research that will facilitate the discovery and development of therapeutics, diagnostics
and vaccines for dangerous pathogens requiring biocontainment. This unique resource
is also a critical resource to educate the next generation of experts in infectious
diseases of global health importance. The GNL actively responds to national public
health emergencies by providing rapid assistance in diagnostics, sharing of critical
reagents, and contributing to the discovery and development of effective medical
countermeasures. To achieve this goal, the GNL maintains cores focused on supporting
safe and secure operations and maintenance of maximum containment research
facilities and to provide unique resources and tools to investigators working in
biocontainment to allow them to rapidly, safely and securely address emerging
infectious diseases and bioterrorism threats. Unique capabilities include the ability to
generate and quantify aerosol challenges of laboratory animals from mice to non-human
primates, access to arthropod vector colonies to support zoonotic disease transmission
studies, and state-of-the-art imaging capabilities to visualize findings, among many
others. Working together, GNL teams conduct basic and applied research that can
transition original discoveries from concept to final product development, validation and
licensure.

## Key facts

- **NIH application ID:** 10857337
- **Project number:** 5UC7AI094660-14
- **Recipient organization:** UNIVERSITY OF TEXAS MED BR GALVESTON
- **Principal Investigator:** Gene Garrard Olinger
- **Activity code:** UC7 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $11,500,000
- **Award type:** 5
- **Project period:** 2011-05-31 → 2026-05-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10857337

## Citation

> US National Institutes of Health, RePORTER application 10857337, Limited Competition: National Biocontainment Laboratories (NBLs) Operations Support (UC7 Clinical Trial Not Allowed) (5UC7AI094660-14). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10857337. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*